Blood test could revolutionize early dementia care
NCT ID NCT07140744
First seen Nov 03, 2025 · Last updated May 18, 2026 · Updated 27 times
Summary
This study is testing whether a blood test that measures a protein called P-tau217 can help doctors make better decisions for people with memory or thinking complaints. Researchers will compare what actions doctors take (like referrals, counseling, or medications) when they have the blood test results versus when they don't. The study involves 7,000 participants and is led by Eli Lilly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBJECTIVE COGNITIVE IMPAIRMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
SiteRx Virtual Site
RECRUITINGNew York, New York, 10013, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.